Worth reading
59In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
0
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
27th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause, mNAV clause, minimum exercise price adjustment clause and exercise suspension clause)
Intended allottee
EVO FUND (allottee at the time of issuance)
Existing Shares and Increase
—Rate of increase
1,274,171,340 shares1,345,340,624Shares
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
The exercise price is adjusted to the closing price on the immediately preceding trading day, or to the minimum exercise price if that closing price is below the minimum exercise price. A minimum exercise price adjustment clause applies.
Number of Stock Acquisition Rights
Total issued: 1,000,000 rights; unexercised at the end of July 2026: 947,300 rights; unexercised at the end of August 2026: 947,300 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Issued on 1 April 2026: 27th Stock Acquisition Rights issued to EVO FUND through a third-party allotment (with an exercise price adjustment clause, mNAV clause, minimum exercise price adjustment clause and exercise suspension clause)
| Item | Details |
|---|---|
| Type of issuance or disposal | 27th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause, mNAV clause, minimum exercise price adjustment clause and exercise suspension clause) |
| Intended allottee | EVO FUND (allottee at the time of issuance) |
| Total number of issued shares | 1,274,171,340 shares (number of listed shares as of the payment date for the issuance) → 1,345,340,624 shares (number of issued common shares as of 31 August 2026) |
| Exercise price | The exercise price is adjusted to the closing price on the immediately preceding trading day, or to the minimum exercise price if that closing price is below the minimum exercise price. A minimum exercise price adjustment clause applies. |
| Number of Stock Acquisition Rights | Total issued: 1,000,000 rights; unexercised at the end of July 2026: 947,300 rights; unexercised at the end of August 2026: 947,300 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Issued on 1 April 2026: 27th Stock Acquisition Rights issued to EVO FUND through a third-party allotment (with an exercise price adjustment clause, mNAV clause, minimum exercise price adjustment clause and exercise suspension clause) |
Items this document does not state (21)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The 23rd through 24th Stock Acquisition Rights are not included in this disclosure because their exercise has been suspended pursuant to the exercise suspension clause. Although the disclosure states that the 27th Stock Acquisition Rights were exercised during August, it does not specify why there were no exercises.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.